CAR-T-cell neurotoxicity: hope is on the horizon

被引：11
|
作者：
Ahmed, Omar [1 ]
机构：
[1] Humanigen, Burlingame, CA 94010 USA
来源：
BLOOD | 2019年 / 133卷 / 20期
关键词：
D O I：
10.1182/blood-2019-03-900985
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In this issue of Blood, Karschnia et al spotlight the "Achilles heel" of chimeric antigen receptor (CAR) T-cell therapy and call for prospective clinical trials to evaluate strategies to manage and potentially prevent CAR T cell-induced neurotoxicity (NT).(1)
引用
收藏
页码：2114 / 2116
页数：5
相关论文
共 50 条
  • [41] A Machine Learning Model for Unstimulated T-Cell Collection in the Cell Therapy Starting Materials for CAR-T-Cell Manufacturing
    AlMozain, N.
    AL-Rasheed, N.
    Alnajjar, F.
    Alalem, S.
    AL-Humaidan, H.
    Alaukili, K.
    Hamideddin, N.
    Ahmed, S.
    Fanega, M.
    Al-Jurf, M.
    [J]. TRANSFUSION, 2023, 63 : 71A - +
  • [42] CAR-T-Cell Therapy with Axicabtagen Ciloleucel New Era in the Therapy of DLBCL and PMBCL
    Ameri, Abdol A.
    [J]. TRANSFUSION MEDICINE AND HEMOTHERAPY, 2019, 46 (01) : 56 - 57
  • [43] Tisagenlecleucel — the first approved CAR-T-cell therapy: implications for payers and policy makers
    Vinay Prasad
    [J]. Nature Reviews Clinical Oncology, 2018, 15 : 11 - 12
  • [44] New insights into the pharmacological, immunological, and CAR-T-cell approaches in the treatment of hepatocellular carcinoma
    Dal Bo, Michele
    De Mattia, Elena
    Baboci, Lorena
    Mezzalira, Silvia
    Cecchin, Erika
    Assaraf, Yehuda G.
    Toffoli, Giuseppe
    [J]. DRUG RESISTANCE UPDATES, 2020, 51
  • [45] Come across in Everyday Care Two Years of CAR-T-Cell Therapy with Kymriah®
    不详
    [J]. TRANSFUSION MEDICINE AND HEMOTHERAPY, 2021, 48 (01) : 70 - 70
  • [46] Evolving CAR-T-Cell Therapy for Cancer Treatment: From Scientific Discovery to Cures
    Majumder, Avisek
    [J]. CANCERS, 2024, 16 (01)
  • [47] Transformed Lymphoma Is Associated with a Favorable Response to CAR-T-Cell Treatment in DLBCL Patients
    Nydegger, Anna
    Novak, Urban
    Kronig, Marie-Noelle
    Legros, Myriam
    Zeerleder, Sacha
    Banz, Yara
    Bacher, Ulrike
    Pabst, Thomas
    [J]. CANCERS, 2021, 13 (23)
  • [48] A novel pharmacologic "ON/OFF" switch to modulate CAR-T-cell function in vitro and in vivo
    Mestermann, Katrin
    Julian, Rydzek
    Silke, Frenz
    Hermann, Einsele
    Hudecek, Michael
    [J]. CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
  • [49] Managing hypogammaglobulinemia in patients treated with CAR-T-cell therapy: key points for clinicians
    Kampouri, Eleftheria
    Walti, Carla S.
    Gauthier, Jordan
    Hill, Joshua A.
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2022, 15 (04) : 305 - 320
  • [50] CAR-T-Cell Therapy for Solid Tumors Positive for Fibronectin Extra Domain B
    Zhang, Zhijie
    Liu, Chang
    Yang, Zhe
    Yin, Hongping
    [J]. CELLS, 2022, 11 (18)
12345